丁型肝炎：当前认知与未来方向。
Hepatitis Delta: Current Knowledge and Future Directions.
作者信息
Lange Marcia, Zaret Dina, Kushner Tatyana
机构信息
Icahn School of Medicine at Mount Sinai, New York, New York.
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
出版信息
Gastroenterol Hepatol (N Y). 2022 Sep;18(9):508-520.
Abstract
Hepatitis delta virus (HDV) infection is caused by a unique circular RNA virus that relies on both the hepatitis B virus (HBV) antigen and human host polymerases for its transmission and replication. HDV infection can be acquired simultaneously with HBV as a coinfection or as a superinfection in patients already chronically infected with HBV. Chronic HDV is the most severe and progressive form of viral hepatitis-induced liver disease, accounting for significant morbidity and mortality worldwide. Despite the severity of disease and poor clinical outcomes, there are few therapeutic options for the treatment of HDV infection. This article discusses the epidemiology of HDV globally and in the United States, the diagnosis and clinical course of HDV infection, and the current and future therapeutic options for the management of HDV infection.
摘要
丁型肝炎病毒（HDV）感染是由一种独特的环状RNA病毒引起的，该病毒的传播和复制依赖于乙型肝炎病毒（HBV）抗原和人类宿主聚合酶。HDV感染可与HBV同时发生，表现为合并感染，也可发生在已慢性感染HBV的患者中，表现为重叠感染。慢性HDV是病毒性肝炎所致肝病中最严重、进展最快的形式，在全球范围内导致了显著的发病率和死亡率。尽管疾病严重且临床预后不佳，但治疗HDV感染的治疗选择却很少。本文讨论了HDV在全球和美国的流行病学、HDV感染的诊断和临床过程，以及HDV感染管理的当前和未来治疗选择。
相似文献
1
Hepatitis Delta: Current Knowledge and Future Directions.丁型肝炎：当前认知与未来方向。
Gastroenterol Hepatol (N Y). 2022 Sep;18(9):508-520.
2
Future treatments for hepatitis delta virus infection.丁型肝炎病毒感染的未来治疗方法。
Liver Int. 2020 Feb;40 Suppl 1:54-60. doi: 10.1111/liv.14356.
3
Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees.在对感染乙型肝炎病毒和丁型肝炎病毒的黑猩猩进行的纵向研究中，不同的细胞因子谱与疾病严重程度和结果相关。
mBio. 2020 Nov 17;11(6):e02580-20. doi: 10.1128/mBio.02580-20.
4
Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus.综述文章：对丁型肝炎病毒的免疫病理学、临床和治疗方面的新见解。
Aliment Pharmacol Ther. 2022 Apr;55(8):978-993. doi: 10.1111/apt.16807. Epub 2022 Mar 16.
5
Beyond bulevirtide: Alternative therapeutic options for the management of hepatitis delta virus.超越贝福替丁：治疗 delta 肝炎病毒的替代治疗选择。
J Viral Hepat. 2023 Apr;30 Suppl 1:33-38. doi: 10.1111/jvh.13789. Epub 2023 Jan 5.
6
An update on HDV: virology, pathogenesis and treatment.丁型肝炎病毒最新进展：病毒学、发病机制与治疗
Antivir Ther. 2013;18(3 Pt B):541-8. doi: 10.3851/IMP2598. Epub 2013 Jun 21.
7
Current status of hepatitis delta.当前的丁型肝炎状况。
Curr Opin Pharmacol. 2021 Jun;58:62-67. doi: 10.1016/j.coph.2021.03.008. Epub 2021 Apr 22.
8
Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.德尔塔病毒感染对埃及慢性乙型肝炎病毒D基因型患者病毒学状态的影响。
J Med Virol. 2016 May;88(5):837-42. doi: 10.1002/jmv.24412. Epub 2015 Nov 13.
9
Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.丁型肝炎病毒感染、复制及其与乙型肝炎病毒的相互作用
World J Gastroenterol. 2014 Oct 28;20(40):14589-97. doi: 10.3748/wjg.v20.i40.14589.
10
Mouse models of hepatitis B and delta virus infection.乙型肝炎和丁型肝炎病毒感染的小鼠模型。
J Immunol Methods. 2014 Aug;410:39-49. doi: 10.1016/j.jim.2014.03.002. Epub 2014 Mar 12.
引用本文的文献
1
Protektem pikinini blong yu trial: protocol for a single arm field trial to assess the effectiveness of treating-all pregnant women with hepatitis B infection with tenofovir prophylaxis to prevent mother-to-child transmission in Vanuatu, 2024-2025.保护您的宝宝试验：一项单臂现场试验方案，旨在评估在瓦努阿图对所有感染乙型肝炎的孕妇使用替诺福韦预防措施以预防母婴传播的有效性，2024 - 2025年。
BMC Public Health. 2024 Dec 18;24(1):3457. doi: 10.1186/s12889-024-20946-3.
2
Hijackers, hitchhikers, or co-drivers? The mysteries of mobilizable genetic elements.劫持者、搭便车者还是同驾者？可移动遗传元件的奥秘。
PLoS Biol. 2024 Aug 29;22(8):e3002796. doi: 10.1371/journal.pbio.3002796. eCollection 2024 Aug.
3
[Delta hepatitis in Africa: epidemiological and clinical particularities].[非洲的丁型肝炎：流行病学和临床特点]
Med Trop Sante Int. 2023 Oct 3;3(4). doi: 10.48327/mtsi.v3i4.2023.430. eCollection 2023 Dec 31.
4
Interferon-Free Regimens and Direct-Acting Antiviral Agents for Delta Hepatitis: Are We There Yet?用于丁型肝炎的无干扰素方案和直接作用抗病毒药物：我们做到了吗？
Curr Issues Mol Biol. 2023 Sep 28;45(10):7878-7890. doi: 10.3390/cimb45100498.
5
Development of quantitative multiplex RT-qPCR one step assay for detection of hepatitis delta virus.用于检测丁型肝炎病毒的定量多重 RT-qPCR 一步法检测试剂盒的研制。
Sci Rep. 2023 Jul 26;13(1):12073. doi: 10.1038/s41598-023-37756-z.
本文引用的文献
1
Bulevirtide with or without pegIFNα for patients with compensated chronic hepatitis delta: From clinical trials to real-world studies.布立伏定联合或不联合聚乙二醇干扰素α治疗代偿期慢性丁型肝炎患者：从临床试验到真实世界研究
J Hepatol. 2022 Nov;77(5):1422-1430. doi: 10.1016/j.jhep.2022.06.010. Epub 2022 Jun 22.
2
Viral hepatitis in 2021: The challenges remaining and how we should tackle them.2021 年的病毒性肝炎：尚存的挑战与应对策略
World J Gastroenterol. 2022 Jan 7;28(1):76-95. doi: 10.3748/wjg.v28.i1.76.
3
Hepatitis D-associated hospitalizations in the United States: 2010-2018.美国与丁型肝炎相关的住院治疗情况：2010-2018 年。
J Viral Hepat. 2022 Mar;29(3):218-226. doi: 10.1111/jvh.13645. Epub 2022 Feb 2.
4
Liver Transplantation for Hepatitis D Virus in the United States: A UNOS Study on Outcomes in the MELD Era.美国丁型肝炎病毒的肝移植：器官共享联合网络（UNOS）关于终末期肝病模型（MELD）时代结局的研究
Transplant Direct. 2021 Dec 17;8(1):e1253. doi: 10.1097/TXD.0000000000001253. eCollection 2022 Jan.
5
A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis.洛那法尼联合ritonavir 与或不联合干扰素α治疗慢性 delta 肝炎的 2 期剂量探索研究。
Hepatology. 2022 Jun;75(6):1551-1565. doi: 10.1002/hep.32259. Epub 2021 Dec 23.
6
The Prevalence and Serological Association of Hepatitis D Virus Genotypes in Taiwan.台湾丁型肝炎病毒基因型的流行率及血清学关联
Pathogens. 2021 Sep 23;10(10):1227. doi: 10.3390/pathogens10101227.
7
Hepatitis B, C and D virus prevalence in children and adults in Mbeya Region, Tanzania: results from a cohort study 2002 - 2009.坦桑尼亚姆贝亚地区儿童和成人乙型、丙型和丁型肝炎病毒流行率：2002-2009 年队列研究结果。
Pan Afr Med J. 2021 Jul 6;39:174. doi: 10.11604/pamj.2021.39.174.26553. eCollection 2021.
8
Seroprevalence and epidemiological characteristics of HDV infection among HBV patients in the Nile Delta, Egypt.埃及尼罗河三角洲地区 HBV 患者中 HDV 感染的血清流行率和流行病学特征。
J Viral Hepat. 2022 Jan;29(1):87-90. doi: 10.1111/jvh.13621. Epub 2021 Oct 7.
9
HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection.中国 HBsAg 阳性患者中 HDV 血清流行率呈高发态势，且与 HCV 单一感染无关。
Viruses. 2021 Sep 10;13(9):1799. doi: 10.3390/v13091799.
10
Hepatitis delta virus: From infection to new therapeutic strategies.丁型肝炎病毒：从感染到新的治疗策略。
World J Gastroenterol. 2021 Jun 28;27(24):3530-3542. doi: 10.3748/wjg.v27.i24.3530.
Zotero 插件